Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cell Imaging”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Not applicableUnknownNCT06227416
What this trial is testing

Skin Tumor Biomarkers by Mass Spectrometry Imaging

Who this might be right for
Skin CancerSquamous Cell CarcinomaBasal Cell Carcinoma+1 more
Bispebjerg Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00918281
What this trial is testing

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Who this might be right for
Solid TumorsHigh Grade GliomasLung Cancer+4 more
GE Healthcare 70
Not applicableNot Yet RecruitingNCT07384949
What this trial is testing

Correlation of Dermoscopic Findings With Histopathological Features and Invasion Depth in Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Cancer
Istanbul Training and Research Hospital 238
Not applicableStudy completedNCT06046144
What this trial is testing

Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors

Who this might be right for
Basal Cell CarcinomaLentigo MalignaMelanoma+3 more
Centre Hospitalier Universitaire de Saint Etienne 161
Not applicableEnded earlyNCT02236546
What this trial is testing

FDG-PET in Advanced Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
ITM Oncologics GmbH 270
Early research (Phase 1)Study completedNCT01295931
What this trial is testing

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 20
Very early researchEnded earlyNCT02591654
What this trial is testing

MRI and PET to Assess Pembrolizumab Response

Who this might be right for
Malignant Melanoma, Metastatic
Columbia University 6
Not applicableUnknownNCT01557205
What this trial is testing

Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging

Who this might be right for
Optical Coherence TomographySkin Cell Imaging
National Taiwan University Hospital 30
Not applicableUnknownNCT03791853
What this trial is testing

Light-CT in the Diagnosis of Breast Tumor and Lymph Node

Who this might be right for
Breast Neoplasms
Peking University People's Hospital 150
Not applicableUnknownNCT02327442
What this trial is testing

68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients

Who this might be right for
GliomaBreast Cancer
Xijing Hospital 46
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT04168528
What this trial is testing

Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

Who this might be right for
Malignant Solid TumorBreast CancerMelanoma (Skin)
Universitair Ziekenhuis Brussel 13
Not applicableStudy completedNCT02217137
What this trial is testing

Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients

Who this might be right for
Dry Eye
Singapore National Eye Centre 80
Not applicableActive Not RecruitingNCT04071691
What this trial is testing

PET Imaging of Giant Cell and Takayasu Arteritis

Who this might be right for
Giant Cell ArteritisTakayasu Arteritis
University of Cambridge 27
Early research (Phase 1)WithdrawnNCT01741597
What this trial is testing

Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more
City of Hope Medical Center
Not applicableLooking for participantsNCT03116412
What this trial is testing

Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

Who this might be right for
Malignant Melanoma
Uppsala University 1,300
Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Not applicableNot Yet RecruitingNCT06273722
What this trial is testing

D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study

Who this might be right for
Basal Cell CarcinomaOptical Coherence Tomography
Maastricht University Medical Center 424
Not applicableStudy completedNCT02056522
What this trial is testing

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Who this might be right for
Skin Lesions
Orlucent, Inc 357
Load More Results